Previous Close | 2.2600 |
Open | 2.3500 |
Bid | 2.2800 x 1000 |
Ask | 2.5400 x 800 |
Day's Range | 2.2900 - 2.3700 |
52 Week Range | 1.6900 - 13.5200 |
Volume | |
Avg. Volume | 155,348 |
Market Cap | 88.862M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.5380 |
Earnings Date | May 11, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 8.00 |
NEW YORK, May 13, 2022--PAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. named Top 50 Healthcare Technology CEO.
NEW YORK, May 11, 2022--Lucid Diagnostics provides business update and preliminary first quarter 2022 financial results.
NEW YORK, May 09, 2022--Lucid’s first commercial payer agreement provides in-network access and payment for its EsoGuard® DNA test to over 8 million covered lives.